Manufacturers in Maryland and Pennsylvania that produce or could produce qualifying personal protective equipment are about to get a clearer view of future federal demand. The U.S. Department of Health and Human Services announced September 18 that it is creating the first recurring department-wide PPE demand forecast, requiring HHS divisions to identify known and reasonably anticipated purchases and update those projections every quarter. The initiative is designed to give domestic suppliers more time to make decisions about staffing, inventory, equipment and production capacity before procurement opportunities arrive.
The forecast is not a contract award and it does not guarantee that a company appearing to match an anticipated need will win business. Instead, it is a planning signal. HHS says each division must maintain a current forecast covering known acquisition requirements as well as recurring purchases, replenishment, seasonal needs, planned programs and potential surge requirements when applicable. The department will consolidate the information and publish it for industry through its Small Business Customer Experience platform, known as SBCX.
The first department-wide quarterly update is due October 15, 2026, followed by updates every January 15, April 15 and July 15. That schedule could matter to smaller manufacturers because one of the hardest parts of government production is deciding whether future demand is large and durable enough to justify new equipment, raw-material purchases or additional shifts. A recurring forecast cannot eliminate procurement uncertainty, but it can reduce the information gap between an agency's internal planning and a supplier's production decisions.
For Pennsylvania, the opportunity sits inside one of the country's larger manufacturing bases. State labor data showed about 555,900 manufacturing jobs in June 2026. In the Pittsburgh metropolitan area alone, manufacturing employment was approximately 88,600 in August. Not all of those companies make medical products, and many would require specialized certifications or production processes to enter the PPE market. But the scale of the industrial base means Pennsylvania has firms with experience in plastics, textiles, filtration, chemicals, packaging, metal fabrication and other capabilities that can overlap with protective-equipment supply chains.
Maryland has a different but complementary profile. The state has a dense life-sciences and medical-technology ecosystem, with Maryland Commerce listing more than 1,800 organizations in its life-sciences directory. Maryland is also home to major HHS agencies and biomedical research institutions. That does not mean those organizations are PPE manufacturers, but it creates a regional network of health-care, regulatory, research and manufacturing expertise that can support companies trying to enter or expand in medical-supply production.
The policy is tied to the Make PPE in America Act, which sought to strengthen domestic production and reduce dependence on foreign supply chains for critical protective equipment. The pandemic exposed how quickly hospitals and government agencies could face shortages when global demand surged at the same time. A recurring forecast is intended to address one lesson from that period: domestic manufacturers are more likely to maintain capacity if they can see a credible pipeline of future demand rather than receiving a sudden emergency order after supply has already tightened.
For a small manufacturer, the most useful part of the forecast may be timing. A company that sees an anticipated procurement months ahead can assess whether it has the machinery, workforce, quality controls, sourcing and certifications needed to compete. It can also decide early that the opportunity is not a fit. That is valuable because federal procurement can impose meaningful bid and compliance costs even before a contract is awarded.
Companies should also distinguish a forecast from a solicitation. The forecast signals anticipated demand, but actual procurements will still be governed by acquisition rules, competition requirements, product specifications and domestic-sourcing requirements. Quantities and dates can change. Some requirements may be canceled, consolidated or purchased through existing vehicles. Manufacturers should use the forecast as an early-warning tool, then monitor the formal procurement systems for the actual opportunity.
Another potential benefit is supply-chain coordination. PPE production often depends on multiple tiers of suppliers for nonwoven materials, elastic, filters, resins, packaging and sterilization or testing services. A prime manufacturer that sees a likely federal requirement can communicate earlier with those suppliers. That can reduce the risk that a company wins an order but cannot obtain the inputs needed to deliver on schedule.
For Maryland and Pennsylvania economic-development organizations, the forecast may also become a business-retention tool. State manufacturing extension programs and local development offices can identify companies with relevant capabilities and help them understand federal registration, quality standards and procurement processes. The strongest candidates may not be firms already branded as PPE manufacturers. A company producing filtration media, specialty plastics or technical textiles for another market might be able to adapt, but only after evaluating standards and economics carefully.
The policy also has limits. Forecast transparency does not solve labor shortages, high capital costs, certification hurdles or competition from established suppliers. It also does not guarantee that agencies will buy enough domestic product to support every new entrant. Companies should avoid investing solely on the assumption that a forecasted opportunity will become a profitable award. The better use is to incorporate the federal signal into a broader market analysis that includes commercial health-care customers and other government buyers.
The first October 15 update will provide the first real test of how useful the system is. Manufacturers should look for the level of detail HHS publishes, including product categories, estimated timing and procurement scale. If the forecast is specific enough to support production planning, it could become a meaningful tool for domestic manufacturers. If it remains high-level, its value may be limited. Either way, Maryland and Pennsylvania companies interested in health-care manufacturing now have a new federal data point to watch each quarter.